Q2 FY27 results and multi-year hospital expansion plan
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty 100 and 2.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 consolidated revenue rose 23% to Rs 76,149 million, EBITDA rose 29% to Rs 11,910 million and profit after tax rose 32% to Rs 6,301 million. Healthcare occupancy was 73%. Apollo plans to expand from 9,605 census beds to about 13,800, with projects through FY29 and FY31 and total planned cost of about Rs 11,150 crore.
Strong PAT growth supports sentiment, but Rs 7,100 crore of expansion spending and new-unit losses may pressure cash flow and margins.